The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
358 - Can you please advise what is required to substantiate a market share claim for a prescription product (i.e. will IMS data suffice)? How long must a market leadership position be maintained in order to make such a claim? How long is the claim valid?
Claims & Support/References for Claims
1
Posts
1
Posters
344
Views
1
Watching
-
Revised August 2019: Yes, IQVIA (formerly IMS Brogan) data can be considered for Rx product market share claims. Refer to this link for the requirements: http://www.paab.ca/resources/pdfs/supplementary-guideline.pdf
